|
Kantrowitz, Joshua T; Hoptman, Matthew J; Leitman, David I et al. (2015) Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia. J Neurosci 35:14909-21
|
|
Kantrowitz, J T; Scaramello, N; Jakubovitz, A et al. (2014) Amusia and protolanguage impairments in schizophrenia. Psychol Med 44:2739-48
|
|
Kantrowitz, J T; Hoptman, M J; Leitman, D I et al. (2014) The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder. Psychol Med 44:25-36
|
|
Guilfoyle, David N; Gerum, Scott V; Sanchez, Jamie L et al. (2013) Functional connectivity fMRI in mouse brain at 7T using isoflurane. J Neurosci Methods 214:144-8
|
|
Javitt, Daniel C (2012) Glycine transport inhibitors in the treatment of schizophrenia. Handb Exp Pharmacol :367-99
|
|
Kantrowitz, Joshua; Javitt, Daniel C (2012) Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Curr Opin Psychiatry 25:96-102
|
|
Moghaddam, Bita; Javitt, Daniel (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37:4-15
|
|
Javitt, Daniel C; Zukin, Stephen R; Heresco-Levy, Uriel et al. (2012) Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr Bull 38:958-66
|
|
Balla, Andrea; Schneider, Samantha; Sershen, Henry et al. (2012) Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia. Eur Neuropsychopharmacol 22:902-10
|
|
Javitt, Daniel C; Schoepp, Darryle; Kalivas, Peter W et al. (2011) Translating glutamate: from pathophysiology to treatment. Sci Transl Med 3:102mr2
|
Showing the most recent 10 out of 61 publications
